One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-149138
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 10 |
Affiliation: The University of Texas MD Anderson Cancer Center, Sarah Cannon, UPMC Hillman Cancer Center, University of Pennsylvania, Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Tokyo National Hospital, Fred Hutch Cancer Center, University of California, San Francisco, Nantes Université, Centre d'Investigation Clinique de Nantes, Centre Hospitalier Universitaire de Nantes, Inserm, University of Miami, Sylvester Comprehensive Cancer Center, Loxo Oncology at Lilly (United States), The Ohio State University, Sir Charles Gairdner Hospital, Linear Clinical Research, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Seoul National University Hospital, University of Oxford, Churchill Hospital, University of North Carolina at Chapel Hill, Swedish Medical Center, Medical College of Wisconsin, Emory University, Columbia University Irving Medical Center, Instytut Hematologii i Transfuzjologi, Istituto di Ematologia di Bologna, University of Bologna, Mary Crowley Cancer Research Center, University Hospitals Plymouth NHS Trust
Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results from the Phase 1/2 BRUIN Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
